Indian mathematician Srinivasa Ramanujan’s formula for Pi can help with calculating black holes, studying percolation, or ...

Brainteasers are a great way to test your cognitive, problem-solving skills and intelligence. Some are designed to improve memory, while others can even test your IQ scores. It's even a great way to ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

It all started one summer lunchtime in 1992 on the terrace outside the CERN cafeteria. If you had happened to be there at the physics research lab near Geneva at the time, you might have overheard ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

The odds are not in your favor when it comes to winning the Powerball’s staggering $1.3 billion jackpot on Wednesday night, but there are a few things you can to tip the scales ever-so-slightly in ...

The odds of winning the Powerball are a dismal 1 in 292,201,338. Still, millions of people take a shot at a dream three times a week and play for a chance to match the numbers on the five white balls ...

From misplaced AirPods to missing luggage, Apple's Find My app has quietly become one of the most essential tools in the Apple ecosystem — and recent updates make it more powerful than ever. Here's ...

There was a time when your landline phone would ring and you automatically answered without knowing who was calling. Today, the introduction of cell phones, voicemail, and caller ID has allowed us to ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...